| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3332328 | HIV & AIDS Review | 2015 | 5 Pages | 
Abstract
												Saquinavir/r containing regimen remains a valuable and safe option for patients with indications to protease inhibitor based antiretroviral treatment.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												J. Kubicka, A. Ignatowska, J.D. Kowalska, I. Cielniak, P. Pulik, E. Bakowska, A. Chylak, E. Burkacka Firlag, A. Horban, 
											